Evidence-based strategies for managing obesity’s impact on heart health, including GLP-1 therapies
Heart and Obesity is an evidence-based course designed for healthcare professionals who want to deepen their understanding of the complex relationship between obesity and cardiovascular health. This program explores both pharmacological approaches—such as GLP-1 receptor agonists and related peptides—and non-pharmacological strategies for improving patient outcomes.
With access to expert-led sessions, live case discussions, and continuously updated research, you’ll gain actionable tools to confidently integrate obesity and cardiovascular risk management into your practice. Plus, higher-tier memberships include interactive Q&A with experts to reinforce clinical decision-making.
In-depth course focusing on the impact of obesity on cardiovascular system and the role of GLP1 agonists and related peptides, including specific protocols and assessments.
Interactive sessions with leading experts in heart health to review cases and course concepts with medical professionals.
Access to e-books, toolkits, and generative AI tools for deep-dive into course content.
Continuously updated with new research to keep content up-to-date.
Opportunities to earn CME credits through specialized programs.
6 sections39 lessons
Integrative Cardiologist & Digital Health Innovator | Founder of Holistic Heart Centers
I’m Dr. Regina Druz, a board-certified cardiologist with over two decades of clinical experience. After training at Cornell and Duke, I recognized the limitations of conventional care and founded the Holistic Heart Centers to integrate evidence-based...
Learn more